Cenovus Energy Inc. (NYSE:CVE) tinted gains of +0.41% (+0.04 points) to US$9.9. The volume of 3.35 Million shares climbed down over an trading activity of 4.53 Million shares. EPS ratio determined by looking at last 12 month figures is -1.78. Over the same time span, the stock marked US$11.47 as its best level and the lowest price reached was US$6.15. The corporation has a market cap of US$11.66 Billion.
Cenovus Energy Inc. (NYSE:CVE)’s earnings per share has been growing at a -36.4 percent rate over the past 5 year when average revenue increase was noted as 2.2 percent. The return on equity ratio or ROE stands at -14.3 percent while most common profitability ratio return on investment (ROI) was -4.3 percent. The company’s institutional ownership is monitored at 73.1 percent. The company’s net profit margin has achieved the current level of -12.8 percent and possesses 58 percent gross margin.
Daily Analyst Recommendations
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 2 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 11 think it is Hold. Recently, analysts have updated the overall rating to 2.36. 12 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.
USA Technologies, Inc. (NASDAQ:USAT) is worth US$297 Million and has recently risen 0.41% to US$4.95. The latest exchange of 0.69 Million shares is below its average trading activity of 1.93 Million shares. The day began at US$5.01 but the price moved to US$5.01 at one point during the trading and finally capitulating to a session high of US$5.01. The stock tapped a 52-week high of US$16.83 while the mean 12-month price target for the shares is US$7.75.
Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 2.36, and a price to sales ratio of 2.32. For the past 5 years, the company’s revenue has grown 0%, while the company’s earnings per share has grown 0%. With an institutional ownership near 71.61%, it carries an earnings per share ratio of -0.25.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 0 brokerage firms polled by Factset Research. At present, 2 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 1 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.67.